Table 5 The association of anal HPV infection with HIV-1 seropositivity by oncogenic type and multiplicity of HPV types.
Anal infection of 37 HPV types | Prevalence of HIV-1 seropositivity n/N (%) | OR (95% CI) | Adjusted OR* (95% CI) |
|---|---|---|---|
By oncogenic type | |||
āNegative for any type | 18/285(6.32) | Ref. | Ref. |
āOnly Positive for low-risk type | 13/118(11.02) | 2.18 (1.30ā3.66) | 2.43 (1.42ā4.16) |
āOnly Positive for high-risk type | 40/291(13.75) | 2.81 (1.39ā5.65) | 2.91 (1.40ā6.02) |
āPositive for both | 30/124(24.19) | 4.86 (2.64ā8.96) | 5.69 (3.00ā10.81) |
By multiplicity of HPV types | |||
ā0 | 18/285(6.32) | Ref. | Ref. |
ā1 | 36/314(11.46) | 2.38 (1.01ā5.59) | 2.64 (1.09ā6.38) |
ā2 | 18/120(15.00) | 3.99 (1.84ā8.63) | 4.18 (1.88ā9.31) |
ā3 | 13/57(22.81) | 5.43 (2.75ā10.75) | 5.59 (2.91ā11.92) |
āā„4 | 19/46(41.30) | 9.85 (4.66ā20.84) | 11.46 (5.25ā25.00) |
āp for trend | Ā | <0.01 | <0.01 |